Announcement

Collapse
No announcement yet.

Eur J Clin Invest. QTc Evaluation in COVID-19 patients treated with Chloroquine/Hydroxichloroquine

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Eur J Clin Invest. QTc Evaluation in COVID-19 patients treated with Chloroquine/Hydroxichloroquine


    Eur J Clin Invest. 2020 May 1:e13258. doi: 10.1111/eci.13258. [Epub ahead of print]
    QTc Evaluation in COVID-19 patients treated with Chloroquine/Hydroxichloroquine.


    Monzani A1, Genoni G2, Scopinaro A3, Pistis G3, Kozel D3, Secco GG3.

    Author information




    Abstract

    In late December 2019, a cluster of pneumonia cases caused by a novel coronavirus occurred in Wuhan, China and has spread rapidly initially throughout Europe and later USA (1). The pathogen was originally called 2019 novel coronavirus (2019-nCoV) and later named severe acute respiratory syndrome coronavirus 2 (SARS-nCoV-2) by the World Health Organization (WHO).
    This article is protected by copyright. All rights reserved.



    PMID:32356580DOI:10.1111/eci.13258

Working...
X